$MIRM
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Healthcare
Sector
Biotechnology
Industry
Christopher Peetz
CEO
334
Employees
$79.25
Current Price
$5.43B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $978,092.91 | 9,943 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 6 | $8,603,803.45 | 86,602 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 10 | $10,775,938.63 | 108,442 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale | 9,943 | $98.37 | $978,092.91 | View Details |
| Sep 2, 2026 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale | 658 | $100.00 | $65,800.00 | View Details |
| Sep 1, 2026 | Peetz Christopher Director | Sale | 8,312 | $98.08 | $815,240.96 | View Details |
| Sep 1, 2026 | Peetz Christopher Director | Sale | 21,688 | $98.91 | $2,145,160.08 | View Details |
| Aug 18, 2026 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale | 40,000 | $100.00 | $4,000,000.00 | View Details |
| Aug 11, 2026 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale | 6,001 | $99.90 | $599,509.50 | View Details |
| Aug 10, 2026 | Peetz Christopher Director | Sale | 2,300 | $100.14 | $230,322.00 | View Details |
| Aug 10, 2026 | Peetz Christopher Director | Sale | 11,683 | $98.51 | $1,150,892.33 | View Details |
| Aug 10, 2026 | Peetz Christopher Director | Sale | 6,017 | $99.25 | $597,187.25 | View Details |
| Aug 3, 2026 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale | 1,840 | $105.29 | $193,733.60 | View Details |
50 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.53
ActualN/A
Revenue
Estimated$178.06M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: